Current filters:  
United States
Healthcare
Food and Drugs Law
United States
Reed Smith
The Pelvic Mesh MDLs are now all but over, with all but a few stragglers either settled or remanded. But the specious logic used in that litigation to overturn decades of precedent that had...
Morrison & Foerster LLP
The House of Representatives recently passed a proposed bill that encourages treatments for rare pediatric diseases by prolonging the authority of Health and Human Services to issue priority review vouchers.
Holland & Knight
More than six months into the pandemic, there is still no easy or definitive answer to the question many retailers are asking about whether there is coverage
Holland & Knight
More than six months into the pandemic, there is still no easy or definitive answer to the question many retailers are asking about whether there is coverage for their business interruption losses related to COVID-19.
Duane Morris LLP
Earlier today, October 13, 2020, Gov. Phil Murphy announced plans to distribute $112 Million of the state's CARES Act money via grants to small businesses and struggling families.
Shipman & Goodwin LLP
Earlier this month, the Centers for Medicare and Medicaid Services (CMS) issued a reminder that its hospital price transparency final rule will become effective January 1, 2021...
Ropes & Gray LLP
On September 24, the U.S. Food and Drug Administration ("FDA") released a final rule enabling states to develop and seek FDA approval of programs for the importation of certain prescription ...
Reed Smith
The heat waves of summer haven't been gone long enough for those of us in the North East to be longing for 90° days anytime soon.
Oblon, McClelland, Maier & Neustadt, L.L.P
In two decisions this year district courts have addressed the "safe harbor" provision of 35 U.S.C. § 271(e)(1) in motions to dismiss a patent infringement count.
Holland & Knight
A hemp trade association and a hemp company have filed a petition in the U.S. Court of Appeals for the District of Columbia Circuit challenging the U.S. Drug Enforcement Administration's (DEA)...
Reed Smith
When we last examined the FDA's sporadic effort to update the archaic "intended use" regulations (primarily 21 C.F.R. §§201.128 (drugs)
Reed Smith
This post is a little different. Several of my colleagues – Reed Smith attorneys Robert J. Hill, Joseph W. Metro, Kevin M. Madagan, Andrew Y. Lu, Sung W. Park, Janine R. Tougas...
Buchanan Ingersoll & Rooney PC
Healthcare was always poised to be a defining issue in the 2020 presidential election.
Proskauer Rose LLP
Judge Louis L. Stanton of the Southern District of New York recently granted defendant Wegmans Food Markets'motion to dismiss claims alleging that Wegmans falsely labels its vanilla ice cream.
Wolf, Greenfield & Sacks, P.C.
The USPTO refused to register the mark BEAN BLOSSOM for "coffee, but not including alcoholic beverages," finding a likelihood of confusion with the registered mark BEANBLOSSOM for "hard cider."
Reed Smith
Lyons v. Boehringer Ingelheim Pharmaceuticals, Inc., 2020 WL 5835125 (N.D. Ga. Sept. 29, 2020), was a wrongful death action alleging that the anticoagulant drug Pradaxa was defective and...
Duane Morris LLP
On September 23, 2020, the U.S. Food and Drug Administration (FDA) published a proposed rule amending the agency's regulations concerning "intended uses."
Mintz
The U.S. Food and Drug Administration (FDA) recently announced what appears to be the first public warning made by the agency to a company promoting an approved prescription drug product...
Mintz
California is the first state in the nation to ban certain ingredients – including formaldehyde, parabens, phthalates...
Torres Law, PLLC
On September 21st, the U. S. Food and Drug Administration (FDA) announced a proposed rule change to the Food Safety Modernization Act (FSMA).
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Popular Authors
Tools
Font Size:
Translation
Mondaq Social Media